Profusa (NASDAQ: PFSA) Receives Positive Nasdaq Listing Decision
Key Developments Profusa, Inc. (NASDAQ: PFSA), a company advancing digital health technology for continuous biochemical monitoring, has received a favorable decision from the Nasdaq Hearings Panel regarding its stock listing status. On May 6, 2026, the panel approved Profusa’s request to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market. This decision allows Profusa (NASDAQ: PFSA) to maintain its Nasdaq presence while it meets specific interim…









